Gene profiling after knocking-down expression of nucleostemin in Hela cells using oligonucleotide DNA microarray

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 4, 2006, Pages 575-583

  Liu, Sijin J ^a,f   Zhang, Z H ^b   Zhang, D Q ^c   Sui, X M ^c   Liu, Y J ^d   Cai, Z W ^e   Yuan, X Y ^b   Sun, L Q ^e   Hu, G F ^a   Liu, R L ^b  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c WEIFANG MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY   (China)

^e MUDANJIANG MEDICAL UNIVERSITY   (China)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

DNA microarray; Hela cells; Nucleostemin

Indexed keywords

MYC PROTEIN; NUCLEOPROTEIN; NUCLEOSTEMIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNINDEXED SEQUENCE;

CARRIER PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; NUCLEAR PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, SMALL INTERFERING;

EID: 33846500109     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hori Y., Rulifson I.C., Tsai B.C., Heit J.J., Cahoy J.D., Kim S.K.: Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc. Natl Acad. Sci. USA 99:16105-16110, 2002.
2. Tsai R.Y., McKay R.D.: A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes & Dev. 16(23):2991-3003, 2002.
3. Liu S.J., Cai Z.W., Liu Y.J., et al.: Role of Nucleostemin in the growth regulation of gastric cancer, liver cancer and other cancers, World J. Gastroenterol., 2004; 10(9):1246-1249.
4. Liu S.J., Cai Z.W., Liu Y.J., et al.: The Effect of Knocking-down Nucleostemin Gene Expression on the in vitro Proliferation and in vivo Tumorigenesis of Hela cells. J. Exp. Clin. Cancer Res. 23(3):529-38, 2004.
5. Zhang L., Zhang Y., Zhou Y., et al.: Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays. J. Antimicrob. Chemother. 49(6):905-15, 2002.
6. Jia M.H., Larossa R.A., Lee J.M., et al.: Global expression profiling of yeast treated with an inhibitor of amino acid biosynthesis, sulfometuron methyl. Physiol Genomics. 3(2):83-92, 2000.
7. Jerry D.J., Dickinson E.S., Roberts A.L., et al.: Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene. J. Dairy Sci. 2002;85(5):1103-10.
8. Porter L.A., Donoghue D.J.: Cyclin B1 and CDK1: nuclear localization and upstream regulators. Prog. Cell Cycle Res. 5:335-47, 2003.
9. Themmen A.P.: Anti-mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr. (34):18-21, 2005.
10. Perlmann T, Wallen-Mackenzie A. Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res. 318(1):45-52, 2004.
11. Ahuja H.S., Szanto A., Nagy L., Davies P.J.: The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death. J. Biol. Regul. Homeost Agents. 17(1):29-45, 2003.
12. Donaldson T.D., Duronio R.J.: Cancer cell biology: Myc wins the competition. Curr. Biol. 14(11):R425-427, 2004.
13. Nilsson J.A., Cleveland J.L.: Myc pathways provoking cell suicide and cancer. Oncogene 22(56):9007-9021, 2003.
14. Bernardi R., Pandolfi P.P.: The nucleolus: at the stem of immortality. Nat. Med. 9:24-25, 2003.
15. Tsai R.Y., McKay R.D.: A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J. Cell. Biol. 168(2):179-84, 2005.
16. Stevaux O., Dyson N.J.: A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell. Biol. 14:684-691, 2002.
17. Black A.R., Azizkhan-Clifford J.: Regulation of E2F: a family of transcription factors involved in proliferation control. Gene 237:281-302, 1999.
18. Matlashewski G., Banks L., Pim D., et al.: Analysis of human p53 proteins and mRNA levels in normal and transformed cells. Eur. J. Biochem. 154(3):665-72, 1986.
19. May E, Jenkins JR, May P. Endogenous Hela p53 proteins are easily detected in Hela cells transfected with mouse deletion mutant p53 gene. Oncogene 6(8):1363-5, 1991.
20. Yamasaki L.: Role of the RB tumor suppressor in cancer. Cancer Treat. Res. 115:209-39, 2003.
21. Okuda T., Higashi Y., Kokame K., et al.: Ndrg 1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves. Mol. Cell. Biol. 24(9):3949-3956, 2004.
22. Kim J.M., Sohn H.Y., Yoon S.Y., et al: Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin. Cancer Res. 11(2 Pt 1):473-482, 2005.
23. Pines J.: Cell cycle: reaching for a role for the Cks proteins. Curr. Biol. 6(11):1399-402, 1996.